Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) CEO Timothy Go bought 10,000 shares of Calumet Specialty Products Partners, L.P stock in a transaction dated Friday, November 18th. The stock was acquired at an average price of $4.75 per share, with a total value of $47,500.00. Following the purchase, the chief executive officer now directly owns 85,913 shares of the company’s stock, valued at $408,086.75. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Timothy Go also recently made the following trade(s):

  • On Wednesday, November 16th, Timothy Go bought 957 shares of Calumet Specialty Products Partners, L.P stock. The stock was acquired at an average price of $4.76 per share, with a total value of $4,555.32.
  • On Friday, November 11th, Timothy Go bought 16,604 shares of Calumet Specialty Products Partners, L.P stock. The stock was acquired at an average price of $3.90 per share, with a total value of $64,755.60.

Shares of Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) remained flat at $4.65 during midday trading on Monday. The company had a trading volume of 298,766 shares. Calumet Specialty Products Partners, L.P has a one year low of $4.65 and a one year high of $4.85. The firm’s 50-day moving average price is $0.00 and its 200-day moving average price is $0.00.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last issued its quarterly earnings results on Thursday, November 3rd. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.10) by $0.32. The business had revenue of $966 million for the quarter, compared to analysts’ expectations of $898.98 million. On average, equities analysts forecast that Calumet Specialty Products Partners, L.P will post ($3.70) earnings per share for the current year.

Insider Buying and Selling by Quarter for Calumet Specialty Products Partners, L.P (NASDAQ:CLMT)

Several research firms have recently weighed in on CLMT. Zacks Investment Research downgraded shares of Calumet Specialty Products Partners, L.P from a “buy” rating to a “hold” rating in a research note on Tuesday, November 8th. Credit Suisse Group AG upgraded shares of Calumet Specialty Products Partners, L.P from an “underperform” rating to a “neutral” rating and set a $5.00 target price for the company in a research note on Friday, November 4th. DA Davidson reaffirmed a “neutral” rating on shares of Calumet Specialty Products Partners, L.P in a research note on Monday, September 19th. Finally, FBR & Co began coverage on shares of Calumet Specialty Products Partners, L.P in a research note on Friday, September 9th. They set a “market perform” rating and a $6.00 price objective for the company. Four analysts have rated the stock with a sell rating and twelve have issued a hold rating to the stock. The company has a consensus rating of “Hold” and an average target price of $9.88.

A number of large investors have recently modified their holdings of CLMT. Commonwealth Equity Services Inc boosted its stake in shares of Calumet Specialty Products Partners, L.P by 11.7% in the second quarter. Commonwealth Equity Services Inc now owns 21,643 shares of the company’s stock valued at $106,000 after buying an additional 2,274 shares during the period. Janney Montgomery Scott LLC boosted its stake in shares of Calumet Specialty Products Partners, L.P by 56.3% in the second quarter. Janney Montgomery Scott LLC now owns 26,488 shares of the company’s stock worth $130,000 after buying an additional 9,545 shares during the last quarter. IFP Advisors Inc boosted its stake in shares of Calumet Specialty Products Partners, L.P by 19.8% in the second quarter. IFP Advisors Inc now owns 29,155 shares of the company’s stock worth $143,000 after buying an additional 4,816 shares during the last quarter. Fifth Third Bancorp boosted its stake in shares of Calumet Specialty Products Partners, L.P by 2.5% in the second quarter. Fifth Third Bancorp now owns 31,050 shares of the company’s stock worth $152,000 after buying an additional 750 shares during the last quarter. Finally, Creative Planning boosted its stake in shares of Calumet Specialty Products Partners, L.P by 5.6% in the third quarter. Creative Planning now owns 35,856 shares of the company’s stock worth $162,000 after buying an additional 1,900 shares during the last quarter.

Calumet Specialty Products Partners, L.P Company Profile

Calumet Specialty Products Partners, L.P. is a producer of specialty hydrocarbon products. The Company operates through three segments. In its specialty products segment, the Company processes crude oil and other feedstocks into a range of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes.

5 Day Chart for NASDAQ:CLMT

Receive News & Stock Ratings for Calumet Specialty Products Partners L.P Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners L.P and related stocks with our FREE daily email newsletter.